产品
编 号:F363310
分子式:C65H104N18O26S4
分子量:1681.89
产品类型
结构图
CAS No: 467426-54-6
联系客服
产品详情
生物活性:
Plecanatide, an analogue of Uroguanylin, is an orally active guanylate cyclase-C (GC-C) receptor agonist. Plecanatide activates GC-C receptors to stimulate cGMP synthesis with an EC50 of 190 nM in T84 cells assay. Plecanatide shows anti-inflammatory activity in models of murine colitis.
体内研究:
Plecanatide (0.5 and 2.5 mg/kg, p.o.) ameliorates spontaneous and chemically induced colitis after treatment for 7 days in BALB/c mice, and 14 days in TCRα-/- mice.Plecanatide (0.005-5 mg/kg, once daily for 7 days) also shows anti-inflammatory activity in dextran sulfate sodium (DSS) and trinitrobenzene sulfonic (TNBS)-induced colitis in BDF-1 mice.Animal Model:Female BALB/c mice (2-4 month old) are induced colitis by TNBS
Dosage:0, 0.5 and 2.5 mg/kg
Administration:P.o. for 7 days
Result:Effectively reduced colitis severity scores as compared to vehicle treatment.
体外研究:
Plecanatide (1 nM-10 μM) activates GC-C receptor to stimulate cyclic guanosine monophosphate (cGMP) synthesis in a dose-dependent manner with EC50 of 190 nM in T84 cells.